Prescription drug · ANDA
Ramipril NDC 51655-347
Ramipril 2.5 mg/1 · Capsule · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51655-347-26 | 51655034726 | 90 CAPSULE in 1 BOTTLE, PLASTIC (51655-347-26)Marketed from May 28, 2020 | |
| 51655-347-52 | 51655034752 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-347-52)Marketed from Oct 27, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ramipril
- Generic name (nonproprietary)
- ramipril
- Active ingredients
- Ramipril — 2.5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077626
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)
- Identifiers
- Product ID 51655-347_4b205d6d-a1f3-79a8-e063-6394a90acea0SPL ID 4b205d6d-a1f3-79a8-e063-6394a90acea0SPL set ID ab324cb3-2aaa-b57f-e053-2995a90a2055RxCUI 198188UNII L35JN3I7SJ
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451655034726followed by a unit qualifier and the quantityPackage 51655-0347-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be used alone or in combination with thiazide diuretics ( 1.1 ). In patients 55 years or older at high risk of developing a major cardiovascular event, Ramipril capsules is indicated to reduce the risk of myocardial infarction, stroke, or death from cardiovascular causes ( 2.2 ). Ramipril capsules are indicated in stable patients who have demonstrated clinical signs of congestive heart failure post-myocardial infarct…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077626
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ramipril | Ramipril 10 mg/1 | CapsuleOral | Proficient Rx LP | 63187-277 |
| Ramipril | Ramipril 2.5 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-3059 |
| Ramipril | Ramipril 1.25 mg/1 | CapsuleOral | Lupin Pharmaceuticals, Inc. | 68180-588 |
| Ramipril | Ramipril 2.5 mg/1 | CapsuleOral | Lupin Pharmaceuticals, Inc. | 68180-589 |
| Ramipril | Ramipril 5 mg/1 | CapsuleOral | Lupin Pharmaceuticals, Inc. | 68180-590 |
| Ramipril | Ramipril 10 mg/1 | CapsuleOral | Lupin Pharmaceuticals, Inc. | 68180-591 |
| Ramipril | Ramipril 5 mg/1 | CapsuleOral | Northwind Health Company, LLC | 51655-144 |
| Ramipril | Ramipril 5 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-9645 |
| Ramipril | Ramipril 10 mg/1 | CapsuleOral | Northwind Health Company, LLC | 51655-346 |
| Ramipril | Ramipril 5 mg/1 | CapsuleOral | Proficient Rx LP | 63187-073 |